Matucci, Andrea
Vultaggio, Alessandra
Danesi, Romano
Article History
Received: 14 May 2018
Accepted: 8 August 2018
First Online: 16 August 2018
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: AM and AV have received payment for lectures and consultant arrangements from Novartis, Glaxo-Smith-Kline, Teva, Astra-Zeneca. AM and AV have received research support from Novartis, Glaxo-Smith-Kline and Sanofi.RD receives research fundings from Pfizer, Boehringher, AstraZeneca, Novartis and Celgene and honoraria from Pfizer, Boehringher, AstraZeneca, Novartis, Janssen, Roche and Celgene. The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.